Three-Tier Business Strategy Aids ADP Amid Intense Competition — Positive
ADP Zacks Investment Research — May 22, 2025The ADP stock is benefiting from its transformation initiative, facilitating higher DataCloud penetration and mid-market migration.

Why Quanta Services (PWR) is a Top Stock for the Long-Term — Positive
PWR Zacks Investment Research — May 22, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

Bilibili (BILI) Crossed Above the 50-Day Moving Average: What That Means for Investors — Positive
BILI Zacks Investment Research — May 22, 2025From a technical perspective, Bilibili (BILI) is looking like an interesting pick, as it just reached a key level of support. BILI recently overtook the 50-day moving average, and this suggests a short-term bullish trend.

Compared to Estimates, Ralph Lauren (RL) Q4 Earnings: A Look at Key Metrics — Positive
RL Zacks Investment Research — May 22, 2025Although the revenue and EPS for Ralph Lauren (RL) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Advance Auto Parts (AAP) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates — Positive
AAP Zacks Investment Research — May 22, 2025Although the revenue and EPS for Advance Auto Parts (AAP) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Here's What Key Metrics Tell Us About Lightspeed POS (LSPD) Q4 Earnings — Positive
LSPD Zacks Investment Research — May 22, 2025The headline numbers for Lightspeed POS (LSPD) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Compared to Estimates, BJ's (BJ) Q1 Earnings: A Look at Key Metrics — Positive
BJ Zacks Investment Research — May 22, 2025The headline numbers for BJ's (BJ) give insight into how the company performed in the quarter ended April 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Analog Devices (ADI) Reports Q2 Earnings: What Key Metrics Have to Say — Positive
ADI Zacks Investment Research — May 22, 2025Although the revenue and EPS for Analog Devices (ADI) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Wall Street Bulls Look Optimistic About Celestica (CLS): Should You Buy? — Neutral
CLS Zacks Investment Research — May 22, 2025The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Rio Tinto (RIO) announced Thursday that CEO Jakob Stausholm would be stepping down later this year after leading the mining and minerals provider since January 2021.

Investigation Alert: Cleveland-Cliffs Inc. (CLF) Under Scrutiny - Contact Levi & Korsinsky for Details — Neutral
CLF Accesswire — May 22, 2025NEW YORK, NY / ACCESS Newswire / May 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cleveland-Cliffs Inc. ("Cleveland-Cliffs Inc.") (NYSE:CLF) concerning possible violations of federal securities laws. Cleveland-Cliffs issued a press release on May 7, 2025, reporting its financial results for the first quarter of 2025.

Fraud Investigation Opened: Levi & Korsinsky Investigates Myriad Genetics, Inc. (MYGN) on Behalf of Shareholders — Neutral
MYGN Accesswire — May 22, 2025NEW YORK, NY / ACCESS Newswire / May 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Myriad Genetics, Inc. ("Myriad Genetics, Inc.") (NASDAQ:MYGN) concerning possible violations of federal securities laws. Myriad released its first quarter 2025 financial results on May 6, 2025, revealing "revenue of $196 million declined by 3% year-over-year" and "pharmacogenomics revenue declined by 20% year-over-year due to UnitedHealthcare (UNH) reducing coverage of GeneSight®.

Meta Platforms, Inc. (META) Under Investigation for Potential Securities Law Violations - Contact Levi & Korsinsky Today — Neutral
META Accesswire — May 22, 2025NEW YORK, NY / ACCESS Newswire / May 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Meta Platforms, Inc. ("Meta Platforms, Inc.") (NASDAQ:META) concerning possible violations of federal securities laws. The Wall Street Journal published an article on May 15, 2025, entitled "Meta Is Delaying the Rollout of Its Flagship AI Model.

Lost Money on Cable One, Inc. (CABO)? Possible Fraud - Contact Levi & Korsinsky Today — Neutral
CABO Accesswire — May 22, 2025NEW YORK, NY / ACCESS Newswire / May 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cable One, Inc. ("Cable One, Inc.") (NYSE:CABO) concerning possible violations of federal securities laws. On May 2, 2025, Cable One missed earnings expectations by nearly $8 and suspended its dividend.

CN to Invest $165 Million in Manitoba to Build Capacity and Power Sustainable Growth — Neutral
CNI GlobeNewsWire — May 22, 2025WINNIPEG, Manitoba, May 22, 2025 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) announced today plans to invest approximately $165 million CAD in Manitoba, as part of its 2025 capital investment program. This investment will support track maintenance and strategic infrastructure initiatives in the province, including upgrade projects to improve operations of rail yards in Winnipeg. These investments will help ensure the safe movement of goods and support long-term sustainable growth in Manitoba and across CN's network.

Lost Money on UroGen Pharma Ltd. (URGN)? Contact Levi & Korsinsky About Investigation — Neutral
URGN Accesswire — May 22, 2025NEW YORK, NY / ACCESS Newswire / May 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of UroGen Pharma Ltd. ("UroGen Pharma Ltd.

Synchronoss unveils AI-powered upgrade to personal cloud platform — Positive
SNCR Proactive Investors — May 22, 2025Synchronoss Technologies Inc (NASDAQ:SNCR) has launched an upgraded version of its Personal Cloud platform, introducing a suite of AI-powered features aimed at helping users rediscover and creatively engage with their digital memories. The new release, version 25.5, includes enhanced photo editing tools, AI-curated memory collections, timeline comparisons, and GPS-integrated photo viewing—all designed to help users navigate and enjoy their growing photo libraries.

NASDAQ: MSTR: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Class Action Lawsuit Against MicroStrategy Incorporated d/b/a Strategy — Neutral
MSTR Business Wire — May 22, 2025RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against MicroStrategy Incorporated d/b/a Strategy (“Strategy”) (NASDAQ: MSTR) on behalf of those who purchased or otherwise acquired Strategy securities between April 30, 2024, and April 4, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is July 15, 2025. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If yo.

Designation underscores EXL's digital innovation and proven success delivering data and AI solutions for global clients Designation underscores EXL's digital innovation and proven success delivering data and AI solutions for global clients
